The pharmaceutical sector receives strong momentum! The FDA appoints a new director to rebuild market confidence, pharmaceutical stocks respond by hitting record highs.

According to the Wise Wealth App, the U.S. Food and Drug Administration announced the appointment of its top cancer drug reviewer, Richard Pazdur, as director of the Center for Drug Evaluation and Research, a move that has pushed the stock prices of global pharmaceutical companies to historic highs.